TrialClinical breast cancer2011

Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trial.

Nicholas J Robert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.